tirzepatide creatinine (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Forest plot showing the effect

These candidates demonstrate clinical differentiation and innovation, moving beyond traditional biosimilar or fast-follower strategies

oral and topical absorption is much lower and less consistent

Why women consider Wegovy Weight management is rarely straightforward for women, and the reasons are largely biological

Probably the game-changing study in the New England Journal, which I was corresponding author on, was STEP 1, which actually launched semaglutide to the world which for the first time caused a result in a 15% weight loss at the end of a year

We realize this can be especially difficult to achieve with additional little ones around, but any support you can lean on to carve out some uninterrupted quiet time to rest is useful